Ebsteins anomaly of the tricuspid valve pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Template:Ebstein's anomaly of the tricuspid valve}}
{{Template:Ebstein's anomaly of the tricuspid valve}}


{{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu]
{{CMG}}


'''Associate Editor-In-Chief:''' {{CZ}}}; [[Priyamvada Singh|Priyamvada Singh, MBBS]] [[mailto:psingh@perfuse.org]] '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@perfuse.org]]
'''Associate Editor-In-Chief:''' {{CZ}}}; Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu];[[Priyamvada Singh|Priyamvada Singh, MBBS]] [[mailto:psingh@perfuse.org]] '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [[mailto:kfeeney@perfuse.org]]


==Overview==
==Overview==

Revision as of 01:40, 20 October 2012

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebsteins anomaly of the tricuspid valve pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebsteins anomaly of the tricuspid valve pathophysiology

CDC on Ebsteins anomaly of the tricuspid valve pathophysiology

Ebsteins anomaly of the tricuspid valve pathophysiology in the news

Blogs on Ebsteins anomaly of the tricuspid valve pathophysiology

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]}; Claudia P. Hochberg, M.D. [3];Priyamvada Singh, MBBS [[4]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[5]]

Overview

The pathophysiology of Ebstein's anomaly depends on the morphology of tricuspid valve and the right ventricle. The annulus of the valve is in normal position. The valve leaflets however, are to a varying degree attached to the walls and septum of the right ventricle. There is subsequent atrialization of a portion of the morphologic right ventricle (which is then contiguous with the right atrium). This causes the right atrium to be large and the anatomic right ventricle to be small in size. 50% of cases involve an atrial shunt (either a PFO or an ASD).

Tricuspid valve

  • The anterior leaflet of the tricuspid valve is malformed in this condition and it is attached to the tricuspid valve annulus or to the right ventricular endocardium
  • The septal and posterior leaflets of the tricuspid valve are absent most of the time
  • Due to these changes, the tricuspid valve may become funnel-shaped and incompetent or leaky

Right ventricle

The right ventricle changes secondary to the malformed tricuspid valves. The right ventricle can be divided into two parts by the malformed valve:

  • The downward extension of the tricuspid valve causes 'atrialization' of the proximal part of the right ventricle
  • The small distal part, the right ventricle proper, thus is reduced in size and sometimes comprises only of the right ventricular outflow tract

Associated Conditions

References

Template:WH Template:WS